World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Best Scientists 256 42 37 27 24 1315 288412
Immunology 260 3 3 2 2 1251 292522
Medicine 263 24 20 18 15 1293 295948

Steven A. Rosenberg publications per year

The chart shows the history of publications by Steven A. Rosenberg between 1964 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Steven A. Rosenberg published across 62 years, from 1964 to 2025, averaging 27.7 papers a year. Output peaked at 374 publications in 2023. 21 of the 1,718 publications appeared in the last two years.

No. of publications
100 200 300
Bar chart. Horizontal axis: year, 1964 to 2025. Vertical axis: number of publications, 0 to 374. Peak 374 publications in 2023. 1964: 1 publication 1965: 1 publication 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 1 publication 1970: 1 publication 1971: 1 publication 1972: 8 publications 1973: 8 publications 1974: 3 publications 1975: 3 publications 1976: 3 publications 1977: 16 publications 1978: 11 publications 1979: 11 publications 1980: 14 publications 1981: 18 publications 1982: 16 publications 1983: 17 publications 1984: 31 publications 1985: 29 publications 1986: 32 publications 1987: 40 publications 1988: 39 publications 1989: 35 publications 1990: 32 publications 1991: 24 publications 1992: 29 publications 1993: 28 publications 1994: 42 publications 1995: 40 publications 1996: 45 publications 1997: 26 publications 1998: 26 publications 1999: 30 publications 2000: 22 publications 2001: 18 publications 2002: 17 publications 2003: 23 publications 2004: 21 publications 2005: 30 publications 2006: 35 publications 2007: 21 publications 2008: 32 publications 2009: 23 publications 2010: 41 publications 2011: 46 publications 2012: 48 publications 2013: 42 publications 2014: 52 publications 2015: 45 publications 2016: 26 publications 2017: 25 publications 2018: 15 publications 2019: 20 publications 2020: 27 publications 2021: 21 publications 2022: 12 publications 2023: 374 publications 2024: 9 publications 2025: 12 publications
1964 2025

1,718 publications in total across all disciplines

View publications per year as a table
Steven A. Rosenberg: publications per year, 1964 to 2025
Year Publications
1964 1
1965 1
1966 0
1967 0
1968 0
1969 1
1970 1
1971 1
1972 8
1973 8
1974 3
1975 3
1976 3
1977 16
1978 11
1979 11
1980 14
1981 18
1982 16
1983 17
1984 31
1985 29
1986 32
1987 40
1988 39
1989 35
1990 32
1991 24
1992 29
1993 28
1994 42
1995 40
1996 45
1997 26
1998 26
1999 30
2000 22
2001 18
2002 17
2003 23
2004 21
2005 30
2006 35
2007 21
2008 32
2009 23
2010 41
2011 46
2012 48
2013 42
2014 52
2015 45
2016 26
2017 25
2018 15
2019 20
2020 27
2021 21
2022 12
2023 374
2024 9
2025 12
Total 1,718
Download as CSV

Steven A. Rosenberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven A. Rosenberg sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 807+ publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 1,251 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100 1,251
Download as CSV

Steven A. Rosenberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven A. Rosenberg sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 157+ D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 260 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96 260
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award
  • 2022 - Research.com Immunology in United States Leader Award
  • 2019 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)
  • 2019 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists
  • 2018 - Albany Medical Center Prize in Medicine and Biomedical Research
  • 2012 - Keio Medical Science Prize, Keio University, Tokyo, Japan
  • 2010 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)
  • 1987 - Member of the National Academy of Medicine (NAM)

Overview

Steven A. Rosenberg is affiliated with the National Institutes of Health in the United States. Their research predominantly focuses on Medicine and Immunology and Microbiology, with subfields including Oncology, Immunology, Molecular Biology, Genetics, and Electrical and Electronic Engineering.

The main topics covered in their work are:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Vaccines and immunoinformatics approaches
  • T-cell and B-cell Immunology

Frequent co-authors collaborating with Steven A. Rosenberg include:

  • Frank J. Lowery
  • Paul F. Robbins
  • Jared J. Gartner
  • Stephanie L. Goff
  • Maria R. Parkhurst

Notable publication venues where Rosenberg has frequently contributed are:

  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Nature Medicine
  • Cancer Cell

Significant recent papers include:

  • "Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer," 2020, Science
  • "Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer," 2022, New England Journal of Medicine
  • "Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers," 2022, Science
  • "Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors," 2020, Cancer Cell
  • "mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer," 2020, Journal of Clinical Investigation

Several awards have been conferred on Steven A. Rosenberg throughout their career, including:

  • Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR), 2019
  • AAI-Steinman Award for Human Immunology Research, American Association of Immunologists, 2019
  • Albany Medical Center Prize in Medicine and Biomedical Research, 2018
  • Keio Medical Science Prize, Keio University, Tokyo, Japan, 2012
  • Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB), 2010
  • Member of the National Academy of Medicine (NAM), 1987

Best Publications

  • Cancer : Principles and Practice of Oncology

    Vincent T. DeVita;Samuel Hellman;Steven A. Rosenberg

  • Cancer regression in patients after transfer of genetically engineered lymphocytes

    Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes

  • Cancer immunotherapy: moving beyond current vaccines.

    Steven A Rosenberg;James C Yang;Nicholas P Restifo

  • Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

    Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang

  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang

  • A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

    James C. Yang;Leah Haworth;Richard M. Sherry;Patrick Hwu

  • Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman

  • Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

    S A Rosenberg;B S Packard;P M Aebersold;D Solomon

  • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Daniel W Lee;James N Kochenderfer;Maryalice Stetler-Stevenson;Yongzhi K Cui

  • Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

    Richard A Morgan;James C Yang;Mio Kitano;Mark E Dudley

  • Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

    Elizabeth A Grimm;A. Mazumder;H. Z. Zhang;S. A. Rosenberg

  • Adoptive cell transfer as personalized immunotherapy for human cancer.

    Steven A. Rosenberg;Nicholas P. Restifo

  • Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

    Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula

  • A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

    Steven A. Rosenberg;Paul Spiess;Rene Lafreniere

  • High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

    Michael B. Atkins;Michael T. Lotze;Janice P. Dutcher;Richard I. Fisher

  • Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Eric Tran;Simon Turcotte;Alena Gros;Paul F. Robbins

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

    R. Michael Blaese;Kenneth W. Culver;A. Dusty Miller;Charles S. Carter

  • Adoptive cell transfer: a clinical path to effective cancer immunotherapy

    Steven A. Rosenberg;Nicholas P. Restifo;James C. Yang;Richard A. Morgan

  • Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry

Frequent Co-Authors

Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Paul F. Robbins
Paul F. Robbins National Cancer Institute
Richard A. Morgan
Richard A. Morgan University of California, Los Angeles
Mark E. Dudley
Mark E. Dudley Novartis (Switzerland)
Suzanne L. Topalian
Suzanne L. Topalian Johns Hopkins University
John R. Wunderlich
John R. Wunderlich National Institutes of Health
James J. Mulé
James J. Mulé University of South Florida
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Maria R. Parkhurst
Maria R. Parkhurst National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Immunology often intersects with various healthcare fields, including nursing and mental health. For those interested in complementary pathways, understanding which programs are accessible is crucial. For example, prospective students can find valuable insights on which LPN programs are easiest to get into, helping them start their clinical careers efficiently.

Similarly, nursing professionals may consider advancing through Nurse Practitioner roles. Information on the easiest NP programs to get into can guide applicants seeking streamlined admission processes.

Mental health specialization is another relevant avenue. Online PMHNP programs with strong support systems enhance clinical experience, and resources highlighting online PMHNP programs with clinical placement offer key information for those wanting hands-on learning opportunities.

Cost often remains a major consideration. Students looking for affordable options can explore comprehensive lists of the cheapest psych NP programs to balance budget with quality education.

By reviewing these resources, immunology students and healthcare professionals alike can make informed decisions about advancing their education and careers in related fields.

Best Scientists Citing Steven A. Rosenberg

Trending Scientists

Recently Published Articles